Adjuvant Pembrolizumab in Resected Stage III Melanoma Reply

被引：0
|
作者：
Eggermont, Alexander M. M. [1 ]
Robert, Caroline [1 ]
Suciu, Stefan [2 ]
机构：
[1] Gustave Roussy Canc Campus Grand Paris, Villejuif, France
[2] European Org Res & Treatment Canc Headquarters, Brussels, Belgium
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 06期
关键词：
HIGH-RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：593 / 595
页数：4
相关论文
共 50 条
  • [31] Impact of adjuvant immunotherapy on survival of patients with resected stage III melanoma diagnosed in 2003-2011 in the US
    Jang, S.
    Wang, H.
    Venna, S.
    MELANOMA RESEARCH, 2016, 26 : E8 - E9
  • [32] Adjuvant Systemic Immunotherapies for Resected Stage III Melanoma: A Single-Centre Retrospective Clinical Practice Review
    Lefas, Alicia Yioli
    Cinar, Cigdem
    Sreekumar, Shruti
    Pakzad, Farrokh
    Koliou, Panagiotis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
  • [33] Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
    Ridolfi, L
    Ridolfi, R
    Riccobon, A
    De Paola, F
    Petrini, M
    Stefanelli, M
    Flamini, E
    Ravaioli, A
    Verdecchia, GM
    Trevisan, G
    Amadori, D
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 156 - 162
  • [34] TREATMENT ADHERENCE AND PROACTIVE ADVERSE EVENT MANAGEMENT FOR ADJUVANT TARGETED THERAPY IN PATIENTS WITH RESECTED STAGE III MELANOMA
    King, Jeanelle
    McGettigan, Suzanne
    Seery, Virginia
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [35] A Real World Study on Adjuvant Nivolumab: Recurrence Free Survival and Toxicity in Resected Stage III and IV Melanoma
    Huang, Wendy E.
    Archer, Christine
    Yip, Desmond
    Kanjanapan, Yada
    Peters, Geoffrey
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 173 - 174
  • [36] The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
    Arak, Haci
    Erkilic, Suna
    Yaslikaya, Sendag
    Mocan, Eda Eylemer
    Aktas, Gokmen
    Ozdemir, Melek
    Semiz, Huseyin Salih
    Kilickap, Saadettin
    Ozalp, Faruk Recep
    Sever, Ozlem Nuray
    Akdag, Goncagul
    Agaoglu, Ahmet Burak
    Ozcelik, Melike
    Sari, Murat
    Arcagok, Murat
    Anik, Hicran
    Yayla, Saziye Burcak
    Sever, Nadiye
    Acar, Fatma Pinar
    Bayrakci, Ismail
    Turhal, Serdar
    Ayhan, Murat
    Kus, Tulay
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (05) : 182 - 189
  • [37] Adjuvant Treatment For Patients With Surgically Resected Advanced-Stage Melanoma
    Grossmann, Kenneth F.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 633 - 635
  • [38] Adjuvant Therapy in Resected Melanoma
    Thomson, Nick
    Doerr, Rachel
    Martin, Michael G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (07): : 678 - 679
  • [39] Skeletal muscle is prognostic in resected stage III malignant melanoma
    Youn, Susie
    Eurich, Dean T.
    McCall, Michael
    Walker, John
    Smylie, Michael
    Sawyer, Michael B.
    CLINICAL NUTRITION, 2022, 41 (05) : 1066 - 1072
  • [40] Association of prior interferon-alpha treatment with the efficacy of adjuvant pembrolizumab in resected melanoma.
    Jin, Gu
    Li, Tao
    Niu, Yanling
    Ma, Tonghui
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345